Inorbit Biotech Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Inorbit Biotech Llp
Inorbit Biotech Llp (IBL) is 3 Year, 5 Months old Limited Liability Partnership 18 August 2021. Its registered office is in Pune, Maharashtra, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAY-2335
-
Incorporation Date
18 Aug 2021
-
Date of Accounts and Solvency Statement
31 Mar 2023
-
ROC Code
Roc-Pune
-
Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Inorbit Biotech Llp?
Designated Partners (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vinod Dagdiya
![]() |
Designated Partner | 18-Aug-2021 | Current |
Mahesh Pawar
![]() |
Designated Partner | 18-Aug-2021 | Current |
Rushikesh Deshmukh
![]() |
Designated Partner | 18-Aug-2021 | Current |
Financial Performance of Inorbit Biotech Llp.
Enhance accessibility to Inorbit Biotech Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
![Graph illustrating revenue growth over time](/Images/financial/revenue-growth.webp)
![Graph showing profit and loss trends over time](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Inorbit Biotech Llp?
Unlock access to Inorbit Biotech Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
![Shareholding Indicator graph](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Charges (Loans)
![Placeholder for charges-related data](/Images/tcc-no-data-images/Charges.webp)
There are no Open Charges registered against the LLP as per our records.
How Many Employees Work at Inorbit Biotech Llp?
Unlock and access historical data on people associated with Inorbit Biotech Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
![Graph showing employee growth trends](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Graph showing company valuation over time](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Inorbit Biotech Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inorbit Biotech Llp's trajectory.
Rating
![Graph displaying rating trends over time](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.